These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8622864)

  • 1. Regulation of nov by WT1: a potential role for nov in nephrogenesis.
    Martinerie C; Chevalier G; Rauscher FJ; Perbal B
    Oncogene; 1996 Apr; 12(7):1479-92. PubMed ID: 8622864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. novH: differential expression in developing kidney and Wilm's tumors.
    Chevalier G; Yeger H; Martinerie C; Laurent M; Alami J; Schofield PN; Perbal B
    Am J Pathol; 1998 Jun; 152(6):1563-75. PubMed ID: 9626060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic alterations associated with pathologic differentiation of Wilms' tumors].
    Chevalier G; Perbal B
    Bull Cancer; 1997 Mar; 84(3):289-303. PubMed ID: 9207876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site.
    Werner H; Rauscher FJ; Sukhatme VP; Drummond IA; Roberts CT; LeRoith D
    J Biol Chem; 1994 Apr; 269(17):12577-82. PubMed ID: 8175666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural analysis of the human nov proto-oncogene and expression in Wilms tumor.
    Martinerie C; Huff V; Joubert I; Badzioch M; Saunders G; Strong L; Perbal B
    Oncogene; 1994 Sep; 9(9):2729-32. PubMed ID: 7520150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of novH is associated with human adrenocortical tumorigenesis.
    Martinerie C; Gicquel C; Louvel A; Laurent M; Schofield PN; Le Bouc Y
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3929-40. PubMed ID: 11502835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation.
    Hewitt SM; Fraizer GC; Wu YJ; Rauscher FJ; Saunders GF
    J Biol Chem; 1996 Apr; 271(15):8588-92. PubMed ID: 8621487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of MAV-1-induced nephroblastoma to the study of genes involved in human Wilms' tumor development.
    Perbal B
    Crit Rev Oncog; 1994; 5(6):589-613. PubMed ID: 8519812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.
    Werner H; Roberts CT; Rauscher FJ; LeRoith D
    J Mol Neurosci; 1996; 7(2):111-23. PubMed ID: 8873895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
    Cook DM; Hinkes MT; Bernfield M; Rauscher FJ
    Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of connective tissue growth factor as a target of WT1 transcriptional regulation.
    Stanhope-Baker P; Williams BR
    J Biol Chem; 2000 Dec; 275(49):38139-50. PubMed ID: 10973960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.
    Gashler AL; Bonthron DT; Madden SL; Rauscher FJ; Collins T; Sukhatme VP
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10984-8. PubMed ID: 1332065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAX 8 regulates human WT1 transcription through a novel DNA binding site.
    Fraizer GC; Shimamura R; Zhang X; Saunders GF
    J Biol Chem; 1997 Dec; 272(49):30678-87. PubMed ID: 9388203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
    Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF
    Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product.
    Dey BR; Sukhatme VP; Roberts AB; Sporn MB; Rauscher FJ; Kim SJ
    Mol Endocrinol; 1994 May; 8(5):595-602. PubMed ID: 8058069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional repression of human insulin-like growth factor-II P4 promoter by Wilms' tumor suppressor WT1.
    Lee YI; Kim SJ
    DNA Cell Biol; 1996 Feb; 15(2):99-104. PubMed ID: 8634146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
    Zhang X; Xing G; Saunders GF
    Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sp1 is a critical regulator of the Wilms' tumor-1 gene.
    Cohen HT; Bossone SA; Zhu G; McDonald GA; Sukhatme VP
    J Biol Chem; 1997 Jan; 272(5):2901-13. PubMed ID: 9006935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.
    Maheswaran S; Englert C; Bennett P; Heinrich G; Haber DA
    Genes Dev; 1995 Sep; 9(17):2143-56. PubMed ID: 7657166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.